Deutz shares fell after it cut its full-year guidance due to lower unit sales and new orders in the third quarter. The company attributed the third quarter performance to poor economic conditions.

Real-estate stocks outperformed in a big way in the third quarter, outpacing the broader S&P 500 index by almost 12%, ...

U.S. Treasury yields were up Thursday morning at levels that didn’t budge much after the Department of Labor released jobless-claims data at 8:30 a.m. Eastern time. The yield on the 10-year Treasury ...

Analysts at RBC Capital Markets expect that a Republican sweep in November's U.S. elections would be the best outcome for the stock market, according to a report shared with MarketWatch on Wednesday.

Export sales of U.S. corn for the week ended Sept. 26 beat the projections of analysts surveyed by The Wall Street Journal this week. In its latest weekly report, the Department of Agriculture said ...

U.S. stock index futures remained lower on the day Thursday after the latest weekly jobless claims data revealed a modest uptick in the number of Americans applying for unemployment benefits last week ...

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...

Salesforce shares have lagged the S&P 500 this year but could be primed for bigger gains thanks to improved product ...

The number of Americans who applied for unemployment benefits last week rose slightly to a minuscule 225,000, affirming that ...

September saw 17 global central banks cut interest rates, the most in any single month since the start of the COVID-19 ...

Investors soothed by the quick recovery for stocks following a rough start to August and September were jolted once again in ...

Aldeyra Therapeutics has once again filed for Food and Drug Administration of its proposed reproxalap drug candidate for the treatment of signs and symptoms of dry-eye disease.